Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Jul 31, 2026
USO Gains +26% Over 30 Days on Renewed Geopolitical Risks, Down -11% for the Quarter

USO Gains +26% Over 30 Days on Renewed Geopolitical Risks, Down -11% for the Quarter

Key Takeaways

  • USO surged approximately 26% over the past 30 days as escalating US-Iran military tensions reignited a geopolitical risk premium across crude oil markets.
  • The fund plunged roughly 11% over the broader quarter, reflecting the mid-June US-Iran peace agreement that briefly reopened the Strait of Hormuz and triggered a historic crude selloff.
  • Renewed threats to maritime chokepoints — including the Strait of Hormuz and Bab el-Mandeb — alongside falling US crude inventories have been the primary catalysts behind the recent rebound.
  • USO's structure as a near-month WTI crude oil futures vehicle makes it highly sensitive to short-term supply disruption fears and geopolitical developments in the Middle East.
  • OPEC+ continues to raise production targets, but actual exportable supply remains constrained by restricted shipping access through key waterways.

USO Overview and How It Tracks Crude Oil

The United States Oil Fund, LP (USO) is a passively managed commodity pool that seeks to track the daily percentage changes in the spot price of West Texas Intermediate (WTI) light, sweet crude oil delivered to Cushing, Oklahoma. Launched in April 2006 by USCF Investments, USO achieves its investment objective primarily by holding near-month NYMEX WTI crude oil futures contracts, supplemented by cash equivalents and short-term government money market instruments.

As of late July 2026, the fund held approximately 8 to 9 securities with total assets under management (AUM) of around $2.1 billion to $2.5 billion. The portfolio is dominated by front-month and second-month WTI crude oil futures, alongside substantial Treasury and government money market collateral positions. The fund carries a net expense ratio of 0.86%. Unlike equity ETFs, USO does not hold corporate stocks; its performance is almost entirely driven by movements in crude oil futures curves, roll yield dynamics, and the interest earned on collateral holdings. This concentrated commodity exposure explains why the fund exhibits extreme sensitivity to geopolitical supply shocks and demand-side macroeconomic shifts.

USO Price Performance: Last 30 Days vs. the Quarter

USO has climbed approximately 26% over the past 30 days, recovering sharply from the multi-month trough reached in early July. The fund traded near $103 in the opening days of July 2026, its lowest level since before the US-Iran conflict began in late February. By the end of July, USO had rebounded above $130, reflecting one of the sharpest monthly rallies since the initial phase of the war.

Over the full quarter, however, USO is down roughly 11%, measured from the end of April when it traded around $147. This quarterly decline captures the dramatic collapse that occurred in mid-June, when the US and Iran reached an interim peace agreement that permitted the reopening of the Strait of Hormuz. Brent crude futures tumbled approximately 30% during the second quarter as more than 60 million barrels of previously trapped oil re-entered global markets. USO's recovery over the past 30 days therefore represents a partial retracement of that earlier selloff, driven by renewed conflict rather than a return to the elevated price levels seen in late April and May.

What Drove the Recent 30-Day Rally in USO

The 30-day rally in USO has been overwhelmingly driven by the re-escalation of military conflict between the United States and Iran, which reversed the brief period of market calm that followed the mid-June peace accord. Several interrelated catalysts have contributed. I also checked this using Tickeron’s AI Screener to see how the fund compares to other energy vehicles during similar volatility spikes.

First, the tentative US-Iran ceasefire collapsed in early July when President Trump declared negotiations over and the US resumed strikes on Iranian military targets. Iran's Islamic Revolutionary Guard Corps responded by warning it would blockade all oil exports from West Asia and launched ballistic missile attacks on US bases in Jordan. These developments rekindled fears of a prolonged disruption to the Strait of Hormuz, through which roughly one-fifth of global oil and gas supplies historically transited.

Second, the conflict expanded geographically. Iran-backed Houthi forces in Yemen declared a naval blockade on Saudi Arabia on July 20 and began targeting Saudi-linked tankers in the Bab el-Mandeb Strait, creating a second major chokepoint for global crude flows. Kuwait reported that Iranian strikes damaged key oil infrastructure, while a drone attack sparked fires on gas vessels at Egypt's Damietta port, threatening the Suez Canal route.

Third, US commercial crude inventories fell by 7.2 million barrels during the week ending July 24, leaving stockpiles approximately 7% below their five-year seasonal average, according to Energy Information Administration data. Tightening domestic supply compounded the geopolitical risk premium. WTI crude futures surged above $85 per barrel by late July, directly lifting USO's near-month futures holdings.

Finally, institutional flows into USO accelerated as traders sought direct crude exposure amid the turmoil. The fund's AUM expanded from approximately $1.88 billion at end-June to over $2.1 billion by mid-July, reflecting renewed speculative and hedging demand.

What Drove USO Performance Over the Last Quarter

USO's negative quarterly performance of approximately 11% tells the story of one of the most volatile periods in crude oil markets in years. In late April and early May, crude prices and USO traded near multi-year highs as the original US-Iran conflict had largely closed the Strait of Hormuz, creating an acute supply shortage. Brent crude briefly exceeded $100 per barrel and USO traded above $150.

The landscape transformed abruptly in mid-June when Washington and Tehran signed a memorandum of understanding to reopen the strait. The agreement unleashed a flood of trapped crude: Iran alone exported an estimated 40 million barrels in the days following the deal. Major Persian Gulf producers — including Saudi Arabia and the UAE — rapidly restored exports to near pre-war levels. OPEC+ simultaneously approved successive monthly production target increases of 188,000 barrels per day for June, July, and August. The combination of restored supply and rising quotas overwhelmed demand, sending Brent below $72 and USO toward $103.

Saudi Arabia compounded the bearish pressure by slashing its August official selling price for Arab Light crude to Asia by $11 per barrel — the largest monthly cut in over two decades — signaling a battle for market share. China, the world's largest crude importer, remained largely absent from spot markets, having reduced imports by approximately 5 million barrels per day compared with pre-war levels. These macro and structural forces drove USO sharply lower before the geopolitical pendulum swung back in July.

USO Outlook: Key Developments to Monitor

The near-term trajectory of USO remains tightly linked to developments in the Middle East conflict, particularly the status of maritime traffic through the Strait of Hormuz and Bab el-Mandeb. Any credible diplomatic breakthrough between Washington and Tehran could rapidly unwind the geopolitical risk premium that has driven the recent rally, while further escalation — especially strikes on energy infrastructure in Saudi Arabia, Kuwait, or the UAE — could push crude prices sharply higher.

OPEC+ producers meet on August 2, with markets watching for signals on whether the alliance will approve another 188,000 barrel-per-day increase for September. Even if higher targets are announced, actual exportable supply may remain constrained as long as shipping routes face security threats and elevated insurance costs.

US inventory data will remain a critical barometer. Refinery utilization near 97% and declining crude stockpiles leave limited buffer against further supply disruptions. The ongoing depletion of the US Strategic Petroleum Reserve — after a record 400-million-barrel release — also means the government has reduced capacity to intervene in physical markets.

Beyond geopolitics, the demand outlook presents a mixed picture. Global oil demand growth is projected to slow to approximately 1.1 million barrels per day in 2026, according to the International Energy Agency, with China's import appetite remaining subdued. Lower crude prices could eventually stimulate demand recovery, but for now the market is caught between bearish supply normalization and bullish conflict-driven disruption risk. Investors in USO should expect continued elevated volatility and monitor shipping data, diplomatic signals, and inventory reports as primary indicators of the fund's direction over the coming months.

AI-Powered Screening for Volatile Commodity ETFs

When analyzing instruments like USO amid fast-moving geopolitical events, I find Tickeron's AI Screener particularly useful for quickly scanning technical signals, volatility metrics, and industry trends across the broader market. It streamlines the process of identifying comparable opportunities without manual chart-by-chart review. AI Screener

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: USO

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


Momentum Indicator for USO turns positive, indicating new upward trend

USO saw its Momentum Indicator move above the 0 level on August 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where USO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

USO moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for USO crossed bullishly above the 50-day moving average on July 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where USO advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 278 cases where USO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for USO moved out of overbought territory on July 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for USO turned negative on August 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where USO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

USO broke above its upper Bollinger Band on July 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks the daily changes in percentage terms of its shares’ per share NAV to reflect the daily changes in percentage terms of the spot price of light, sweet crude oil delivered to Cushing, Oklahoma, as measured by the daily changes in the price of a specified short-term futures contract on light, sweet crude oil called the “Benchmark Oil Futures Contract,” plus interest earned on USO’s collateral holdings, less USO’s expenses. USO seeks to achieve its investment objective by investing primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
View a ticker or compare two or three
USO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category CommoditiesBroadBasket

Profile
Details
Category
Commodities Focused
Address
1320 Harbor Bay ParkwaySuite 145Almadeda
Phone
403-233-9366
Web
www.unitedstatesoilfund.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.